SCHEMBL15824060

SCHEMBL15824060

COc1cc(NC(=O)OCCCc2ccc(-c3ccccc3)c(NC(=O)O)c2)c(Cl)cc1CO

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TSHR P16473 1/20 0.42
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
CHRM3 P20309 4/20 0.40
KMT2A Q03164 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.38
ACHE P22303 2/20 0.37
HPGD P15428 1/20 0.36
BCHE P06276 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15822677 0.88 ALDH1A1 (0.41) ALDH1A1LMNANPSR1L3MBTL1TSHR
SCHEMBL101634 0.88 POLB (0.46) ALDH1A1LMNANPSR1L3MBTL1PDCD1
SCHEMBL15823470 0.87 ALDH1A1 (0.37) ALDH1A1LMNANPSR1L3MBTL1TSHR
SCHEMBL100422 0.85 HPGD (0.51) ALDH1A1NPSR1PDCD1CD274KMT2A
SCHEMBL17259763 0.80 CHRM3 (0.52) CHRM3
SCHEMBL17259761 0.80 CHRM3 (0.52) CHRM3
SCHEMBL15822284 0.80 NPC1 (0.43) ALDH1A1LMNAKMT2ANPC1RAB9A
SCHEMBL99878 0.79 KDM4E (0.43) ALDH1A1NPSR1L3MBTL1KMT2ANPC1
SCHEMBL15823026 0.78 ADRB2 (0.63) CHRM3
SCHEMBL15823022 0.78 ADRB2 (0.63) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed